Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 18, 2026

Mar. 18, 2026

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

GlobeNewswire

Mar. 18, 2026

2026 MAP Awards presented to 20 organizations for high performance in revenue cycle

GlobeNewswire

Mar. 18, 2026

VitalHub Reports Fourth Quarter 2025 Results

GlobeNewswire

Mar. 18, 2026

Alvotech Q4 2025 and Full Year 2025 Financial Results

GlobeNewswire

Mar. 18, 2026

Ever Joint Claims Evaluated: What the Science Says About EverJoint Joint Support Ingredients

GlobeNewswire

Mar. 18, 2026

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

GlobeNewswire

Mar. 18, 2026

SnoreStop Throat Spray Claims Evaluated: Effective Anti-Snoring Oral Solution with Clinically Proven Ingredients

GlobeNewswire

Mar. 18, 2026

ADR Ratio Change

GlobeNewswire

Mar. 18, 2026

Extendicare Announces Proposed Changes to Board of Directors

GlobeNewswire

Mar. 18, 2026

Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026

GlobeNewswire

Mar. 18, 2026

Big Ed's Meds Under Investigation: Safe FDA-Approved ED Medications for Men

GlobeNewswire

Mar. 18, 2026

XOMA Royalty Declares Quarterly Preferred Stock Dividends

GlobeNewswire

Mar. 18, 2026

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

GlobeNewswire

Mar. 18, 2026

Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson’s Disease

GlobeNewswire

Mar. 18, 2026

BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire

Mar. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 18, 2026

4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones

GlobeNewswire

Mar. 18, 2026

Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

GlobeNewswire

Mar. 18, 2026

ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

GlobeNewswire

Mar. 18, 2026

Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

GlobeNewswire